Both EMG and NCS are usually required for a clinical diagnosis of peripheral nervous system disorders. Performance of one type of testing does not eliminate the need for the other. The intensity and extent of testing with EMG and NCS are matters of clinical judgment developed after the initial pre-test evaluation, and later modified during the testing procedure.
Decisions to continue, modify or conclude a testing rely on knowledge of anatomy, physiology and neuromuscular diseases. Ongoing real-time assessment of data is required during the clinical diagnostic evaluation and especially during EMG examination.
NCS are used to measure action potentials resulting from peripheral nerve stimulation which are recordable over the nerve or from an innervated muscle. With this technique, responses are measured between two sites of stimulation or between a stimulus and a recording site.
NCS are of two general types: sensory and motor. Either surface or needle electrodes can be used to stimulate the nerve or record the response. Axonal damage or dysfunction generally results in loss of nerve or muscle potential response amplitude; whereas, demyelination leads to prolongation of conduction time and slowing of conduction velocity.
Obtaining and interpreting NCS results requires extensive interaction between the performing, qualified, health care professional and patient, and is most effective when both obtaining raw data and interpretation are performed concurrently on a real-time basis.
Results of the NCS reflect on the integrity and function of: (I) the myelin sheath (Schwann cell derived insulation covering an axon), and (II) the axon (an extension of neuronal cell body) of a nerve. Interruption of axon and dysfunction of myelin will both affect NCS results.
It is also often valuable to test conduction status in proximal segments of peripheral nerves. This assessment can be accomplished by H-reflex, F-wave and blink reflex testing. These proximal segments include the first several centimeters of a compound nerve emerging from the spinal cord or brainstem. H-reflex, F-waves and Blink reflex testing accomplish this task better than distal NCS.
EMG is the study and recording of intrinsic electrical properties of skeletal muscles. This is carried out with a needle electrode. Generally, the needles are one of two types: monopolar or concentric. EMG is undertaken together with NCS. Unlike NCS, however, EMG testing relies on both auditory and visual feedback to the electromyographer. This testing is invasive in that it requires needle electrode insertion and adjustment at multiple sites which are at times, anatomically critical. As in NCS, during EMG studies, the electromyographer depends on ongoing real-time interpretation of clinical diagnoses being evaluated to decide whether to continue, modify, or conclude a test. This process requires knowledge of anatomy, physiology, and neuromuscular diseases.
EMG results reflect not only the integrity of the functioning connection between a nerve and its innervated muscle but also the integrity of the muscle itself. The axon innervating a muscle is primarily responsible for the muscle's volitional contraction, survival, and trophic functions. Thus, interruption of the axon will alter the EMG. A few prime examples of conditions in which EMG is potentially helpful are disc disease producing spinal nerve dysfunction, advanced nerve compression in peripheral lesions, Amyotrophic Lateral Sclerosis (ALS), and polyneuropathy. After an acute neurogenic lesion, EMG changes may not appear for several days to weeks in the innervated muscles. Primary muscle disease such as polymyositis will also alter a normal EMG pattern. Myotonic disorders may show a pattern of spontaneous repetitive discharges on needle exploration.
In summary, axonal and muscle involvement are most sensitively detected by EMG and myelin and axonal involvement are best detected by NCS.
Physical Therapists Performing EMGs
Program Memorandum Transmittal B-01-28/Change Request 850 sets forth revised levels of physician supervision required for diagnostic tests payable under the Medicare Physician Fee Schedule. Effective July 1, 2001, certain codes in the range of CPT 95860-95937 were assigned new supervision levels (21, 22, 6a, 66, 77 or 7a) . This implementation date would make it possible for physical therapists to acquire the certification required to perform these services without supervision. A physical therapist who is presently certified by the American Board of Physical Therapy Specialties can perform procedures assigned level of 21, 22, 
Nerve Conduction Studies
The dichotomy into axonal and demyelinating neuropathies provides a practical means of correlating electrical abnormalities with major pathophysiologic changes in the nerve. Electrical studies can be of help in localization of an abnormality, and in distinguishing one variety of neuropathy from another: for example, diffuse vs. multifocal; axonal vs. demyelinating. Such distinction has diagnostic value. Specific classification of nerve injuries into neuropraxia and axonotmesis can be made on the basis of conduction studies and electromyography. Such classification has a bearing on prognosis and treatment. The broad diagnostic scope of NCS is recognizable by the foregoing description. There may be instances where questions about an indication, or need for a study, will arise. The clinical history and examination, carried out before the study, must always describe and document clearly and comprehensibly the need for the planned test. A "rule-out" diagnosis is typically not acceptable, and instead it is required that the medical record establishes the necessity of the testing by making clear how the test results will alter management of the specific patient. The Contractor is cognizant of the fact that patients are not always referred with a definite diagnosis in mind. Often, pain, paresthesia, or weakness in an extremity is the reason for an NCS or EMG. These common symptoms result not only from axonal and myelin dysfunction but also from systemic, non-neurological illnesses. EMG and NCV may help in making this distinction. Therefore, symptom-based diagnoses such as "pain in limb" weakness, disturbance in skin sensation or "paresthesia" are acceptable provided the clinical assessment unequivocally supports the need for a study. To cite but one example of many, an EMG or NCS is irrelevant as a first order diagnostic test for limb pain resulting from immediate antecedent trauma or acute bone injury.
Both EMGs and NCSs are required for a clinical diagnosis of peripheral nervous system disorders. EMG results reflect on the integrity of the functioning connection between a nerve and its innervated muscle and also on the integrity of a muscle itself. Performance of one may not eliminate the need for the other. The intensity and extent of testing with EMG and NCS are matters of clinical judgment developed after the initial pre-test evaluation, and later modified during the testing procedure. Decisions to continue, modify or conclude a test also rely on a knowledge base of anatomy, physiology and neuromuscular diseases. There is a requirement for ongoing real-time clinical diagnostic evaluation, especially during EMG examination. Also, EMG examination is invasive. Needle placement in the exact muscle of interest is essential. It requires needle exploration near vital structures as the pleura, femoral neurovascular bundle, peritoneum, intraspinal spaces, carotid artery, orbit and brachial plexus. Risk of infection from AIDS, Hepatitis B-E, Creutzfeldt-Jakob encephalopathy, and hemorrhage from anticoagulation can be managed by proper techniques.
The electrodiagnostic evaluation is actually an extension of the neurologic portion of the physical examination. Both require a detailed knowledge of a patient and his/her disease. Training in the performance of electrodiagnostic procedures, in isolation without awareness and ability to diagnose and manage neuromuscular diseases, is often inadequate for electrodiagnostic consultation. Recognition and experience in the management of disparate diseases that produce common electrodiagnostic findings may be necessary. For example, EMG-NCS findings may overlap in the following pairs of disorders: inflammatory myopathies and ALS, ALS and multi-level radiculopathies, myotonia of channelopathies (periodic paralyses) and myotonic dystrophies, focal neuropathies as Carpal Tunnel Syndrome and proximal plexopathies. Other instances where knowledge of disease behavior is crucial are Chronic Inflammatory Demyelinating Neuropathy (CIDP) and Multifocal Motor Neuropathy. These entities display electrodiagnostic features that resemble generalized polyneuropathies. Neuromuscular transmission disorders require separation based on clinical presentation and electrical features. Treatment will depend on differentiating among them. Without awareness of the disease spectrum, diagnosis solely by EMG-NCS findings may be wrong, detrimental to the patient or both. c. Mixed NCSs are performed by applying electrical stimulation near a nerve containing both motor and sensory fibers (a mixed nerve) and recording from a different location along that nerve that also contains both motor and sensory nerve fibers. Response parameters include amplitude, latency, configuration, and motor conduction velocity."
CPT code 95905 -Nerve conduction studies performed using automated devices (for example devices such as NC-stat® System) cannot support testing of other locations and other nerves as needed depending on the concurrent results of testing and must not be billed with the current CPT codes.
When the beneficiary has a high pre-test or a priori probability for having the diagnosis of Carpal Tunnel Syndrome, the NC-stat® System (alone) will be allowed, one service per arm, using CPT code 95905. The diagnosis code G56.00 -G56.03 should be used. All other diagnosis codes will be denied as not medically necessary.
Nerve conduction studies performed independent of needle electromyography (EMG) may only provide a portion of the information needed to diagnose muscle, nerve root, and most nerve disorders. When the nerve conduction study (NCS) is used on its own without integrating needle EMG findings or when an individual relies solely on a review of NCS data, the results can be misleading, and important diagnoses may be missed.
In most instances, both NCS and usually EMG are necessary to perform diagnostic testing. While a provider may choose to perform just a NCS, when performed alone it is usually considered be a screening exam. The only exception to this is a situation when a provider may consider it appropriate to perform a NCS without doing an EMG for the diagnosis of carpal tunnel syndrome with a high pre-test probability.
Electromyography
Neurogenic disorders can be distinguishable from myopathic disorders by a carefully performed EMG. For example, both polymyositis and ALS (Amyotrophic Lateral Sclerosis) produce manifest weakness. The former carries a very different prognosis and treatment than the latter. An EMG is valuable in making this distinction. Similarly, classification of nerve trauma into axonal vs. demyelinating categories, with corresponding differences in prognoses, are possible with EMG. Below is a list of common disorders where an EMG, in tandem with properly conducted NCS, will be helpful in diagnosis:
1. Nerve compression syndromes, including carpal tunnel syndrome and other focal compressions. 2. Radiculopathy -cervical, lumbosacral. 3. Mono/polyneuropathy -metabolic, degenerative, hereditary. 4. Myopathy -including poly-and dermatomyositis, myotonic and congenital myopathies. 5. Plexopathy -idiopathic, trauma, infiltration. 6. Neuromuscular junction disorders -myasthenia gravis. Single fiber EMG is of special value here. 7. When clinically necessary, immediately prior to botulinum toxin injection, for localization. 8. When clinically necessary, immediately prior to injection of phenol or other substances for nerve blocking or chemodenervation.
There may be other instances, not detailed here, where EMG may be of use.
Use of EMG with Botulinum Toxin Injection
EMG may be used to optimize the anatomic location of botulinum toxin injection. It is expected there will be one study performed per anatomic location of injection, if needed, and that the record will evidence the necessity for use of EMG.
Limitations:

Nerve Conduction Studies
Each descriptor (code) from codes 95907, 95908, 59509, 95910, 95911, 95912, and 95913 can be reimbursed only once per nerve, or named branch of a nerve, regardless of the number of sites tested or the number of methods used on that nerve. For instance, testing the ulnar nerve at wrist, forearm, below elbow, above elbow, axilla and supraclavicular regions will all be considered as a single nerve. Motor and sensory nerve testing are considered separate tests. CPT code 95905 is payable only once per limb studied and cannot be used in conjunction with any other nerve conduction codes.
Screening testing for polyneuropathy of diabetes or endstage renal disease (ESRD) is NOT covered. Testing for the sole purpose of monitoring disease intensity or treatment efficacy in these two conditions is also not covered.
Psychophysical measurements (current, vibration, thermal perceptions), even though they may involve delivery of a stimulus, are considered to be part of the physical exam and may not be billed as a separate service. Examination using portable hand-held devices or devices which are incapable of real-time wave-form display and analysis and incapable of both NCS and EMG testing will be included in the E/M service. They will not be paid separately. Examples include; The Axon II or delta fiber analysis testing and/or similarly limited machines with other names.
Current Perception
NCS must provide a number of response parameters in a real-time fashion to facilitate provider interpretation. Those parameters include amplitude, latency, configuration and conduction velocity. Diagnostic studies are not accepted that do not provide this information or those that provide delayed interpretation as substitutes for NCS. Raw measurement data obtained and transmitted transtelephonically or over the Internet, therefore, does not qualify for the payment of the electrodiagnostic service codes included in this LCD.
It is not expected to receive claims for nerve conduction testing accomplished with discriminatory devices that use fixed anatomic templates and computer-generated reports used as an adjunct to physical examination routinely on all patients and these must not be submitted using the codes in this LCD.
Electromyography
It is expected that providers will use CPT code 95870 for sampling muscles other than the paraspinals associated with the extremities, which have been tested. It is not expected to see this code billed when the paraspinal muscles corresponding to an extremity are tested and when the extremity EMG code 95860, 95861, 95863 or 95864 is also billed. The necessity and reasonableness of the following uses of EMG studies have not been established:
• exclusive testing of intrinsic foot muscles in the diagnosis of proximal lesions • definitive diagnostic conclusions based on paraspinal EMG in regions bearing scar of past surgeries (e.g., previous laminectomies) • pattern-setting limited limb muscle examinations, without paraspinal muscle testing for a diagnosis of radiculopathy • EMG testing shortly after trauma, before EMG abnormalities would have reasonably had time to develop • surface and macro EMGs • multiple uses of EMG in the same patient at the same location of the same limb for the purpose of optimizing botulinum toxin injections. 
Type of bill Code
Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the policy does not apply to that Bill Type. Complete absence of all Bill Types indicates that coverage is not influenced by Bill Type and the policy should be assumed to apply equally to all claims Limited study of muscles in one extremity or non-limb (axial) muscles (unilateral or bilateral), other than thoracic paraspinal, cranial nerve supplied muscles or sphincters 95872
Needle electromyography using single fiber electrode, with quantitative measurement of jitter, blocking and/or fiber density, any/all sites of each muscle studied 95874
Needle electromyography for guidance in conjunction with chemodenervation (list separately in addition to code for primary procedure) 95885
Needle electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; limited (list separately in addition to code for primary procedure) 95886
Complete, five or more muscles studied, innervated by three or more nerves or four or more spinal levels (list separately in addition to code for primary procedure) 95887
Needle electromyography, non-extremity (cranial nerve supplied or axial) muscles(s) done with nerve conduction, amplitude and latency/velocity studies (list separately in addition to code for primary procedure)
Does the CPT 30% Rule Apply
No
ICD-10 Codes that Support Medical Necessity
Note: Diagnosis codes must be coded to the highest level of specificity. 51785, 92265, 95860, 95861, 95863, 95864, 95865, 95866, 95867, 95868, 95869, 95870, 95872, 95873, 95874,  95885, 95886, 95887, 95907, 95908, 95909, 95910, 95911, 95912, 95913 , 95933, and 95937:
Procedure codes
A05.1 Botulism food poisoning A35
Other tetanus A52. 15 Late syphilitic neuropathy B91 Sequelae of Poliomyelitis C70.0 -C70. 9 Malignant neoplasm of meninges C72.0 -C72. 9 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system C79.31-C79. 49 Secondary malignant neoplasm of other and unspecified sites D32. 1 Benign neoplasm of spinal meninges D33.3 -D33. 7 Benign neoplasm of brain and other parts of central nervous system E08.40-E08.49
Diabetes mellitus due to underlying condition with neurological complications E08.610
Diabetes mellitus due to underlying condition with diabetic neuropathic arthropathy E09.40-E09. Other specified diabetes mellitus with neurological complications E13.610
Other specified diabetes mellitus with diabetic neuropathic arthropathy E51.2 -E51. 9 Thiamine deficiency E56.0
Deficiency of vitamin E E56. 8 Deficiency of other vitamins E78. 6 Lipoprotein deficiency G04. 1 Tropical spastic paraplegia G11.0 -G12. 9 Systemic atrophies primarily affecting the central nervous system G13.0 -G13. 1 Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere G14 Postpolio syndrome G20
Parkinson's disease G21. 4 Vascular parkinsonism G24.01-G24.9 Dystonia G25.3 Myoclonus G25.61-G25. 69 Drug induced tics and other tics of organic origin G25.89-G25. 9 Other extrapyramidal and movement disorders G32.0 -G32.81
Other degenerative disorders of nervous system in diseases classified elsewhere G35 -G37. 9 Diseases of the nervous system G50.0 -G50. 9 Disorders of trigeminal nerve G51.2 -G51. 9 Facial nerve disorders G52.1 -G61.89
Diseases of the nervous system G62.0 -G62.89
Other and unspecified polyneuropathies G63 -G65. 2 Polyneuropathies and other disorders of the peripheral nervous system G70.00-G73. 7 Diseases of myoneural junction and muscle G80.0 -G80. 9 Cerebral palsy G81.00-G81. 94 Hemiplegia and hemiparesis G82.20-G83. 9 Diseases of the nervous system G90.01-G90.09
Idiopathic peripheral autonomic neuropathy G90. 2 Horner's syndrome G90.4 -G90.9 Disorders of autonomic nervous system G93. 3 Postviral fatigue syndrome G95.0 -G95. 9 Other and unspecified diseases of spinal cord G99.0 -G99. 2 Other disorders of nervous system in diseases classified elsewhere H02.141-H02. 149 Spastic ectropion of eyelid H02.401-H02. 409 Unspecified ptosis of eyelid H02.421-H02. 439 Ptosis of eyelid H49.00-H49. 43 Paralytic strabismus H49.881-H51. 9 Disorders of ocular muscles, binocular movement, accommodation and refraction H53.2 Diplopia I95.1
Orthostatic hypotension J38.00-J38.02
Paralysis of vocal cords and larynx J38. 5 Laryngeal spasm J38. 7 Other diseases of larynx K22. Other spondylopathies M48. 9 Spondylopathy, unspecified M50.00-M50. 03 Cervical disc disorder with myelopathy M50.10-M50. 13 Cervical disc disorder with radiculopathy M50. 20-M50.33 Cervical disc disorders M50.80-M50. 93 Cervical disc disorders M51.04-M51.06
Thoracic, thoracolumbar and lumbosacral intervertebral disc disorders with myelopathy M51.14-M51. 17 Thoracic, thoracolumbar and lumbosacral intervertebral disc disorders with radiculopathy M51. 24-M51.47 Thoracic, thoracolumbar, and lumbosacral intervertebral disc disorders M51.84-M51.87
Other thoracic, thoracolumbar and lumbosacral intervertebral disc disorders M51. 9 Unspecified thoracic, thoracolumbar and lumbosacral intervertebral disc disorder M53.82
Other specified dorsopathies, cervical region M54. 10 Interventebral disc stenosis of neural canal M99.60-M99.69
Osseous and subluxation stenosis of intervertebral foramina M99.70-M99. 79 Connective tissue and disc stenosis of intervertebral foramina N39.3 -N39. 498 Other disorders of urinary system Q05.0 -Q05. 9 Spina bifida Q06.2 Diastematomyelia Q07.00-Q07.03
Arnold-Chiari syndrome Q68.0
Congenital deformity of sternocleidomastoid muscle Q85.00-Q85.09
Neurofibromatosis (nonmalignant) R15.0 -R15. 9 Fecal incontinence R20.0 -R20. 9 Disturbances of skin sensation R25.0-R25. 9 Abnormal involuntary movements R26.0-R26. 1 Abnormalities of gait and mobility R26.81-R27. 9 Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified R29.0 Tetany R29. 5 Transient paralysis R29.898
Other symptoms and signs involving the musculoskeletal system R32 Unspecified urinary incontinence R39.14 Feeling of incomplete bladder emptying R41.1-R41. 3 Other symptoms and signs involving cognitive functions and awareness R41. 9 Unspecified symptoms and signs involving cognitive junctions and awareness R45.83-R45. 84 Other symptoms and signs involving emotional state R47.02-R47. 9 Speech disturbances, not elsewhere classified R49.0 -R49. 9 Voice and resonance disorders R53.0 -R53. Injury of other cranial nerves S12.000A-S12.001S
Unspecified fracture of first cervical vertebra S12.100A-S12.101S
Unspecified fracture of second cervical vertebra S12.200A-S12.201S
Unspecified fracture of third cervical vertebra S12.300A-S12.301S
Unspecified fracture of fourth cervical vertebra S12.400A-S12. 401S Unspecified fracture of fifth cervical vertebra S12.500A-S12.501S
Unspecified fracture of sixth cervical vertebra S12.600A-S12.601S
Unspecified fracture of seventh cervical vertebra S14.0XXA-S14.9XXS
Injury of nerves and spinal cord at neck level S22.019A-S22.019S
Unspecified fracture of first thoracic vertebra S22.029A-S22.029S
Unspecified fracture of second thoracic vertebra S22.039A-S22.039S
Unspecified fracture of third thoracic vertebra S22.049A-S22.049S
Unspecified fracture of forth thoracic vertebra S22.059A-S22.059S
Unspecified fracture of T5-T6 vertebra S22.069A-S22.069S
Unspecified fracture of T7-T8 vertebra S22.079A-S22.079S
Unspecified fracture of T9-T10 vertebra S22.089A-S22.089S
Unspecified fracture of T11-T12 vertebra S24.0XXA-S24.104S
Injury of nerves and spinal cord at thorax level Injury of nerves at wrist and hand level S74.00XA-S74.92XS
Injury of nerves at hip and thigh level S84.00XA-S84.92XS
Injury of tibial nerve at lower leg level S94.01XA-S94.92XS
Injury of nerves at ankle and foot level
Coverage for CPT code 95905 is limited to the following:
G56.00-G56.03 Carpal tunnel syndrome
ICD-10 Codes that DO NOT Support Medical Necessity
All diagnoses not listed in the "ICD-10 Codes that Support Medical Necessity."
Associated Information Documentation Requirements
The patient's medical records must clearly document the medical necessity for the test. It is not necessary to include documentation with each claim submission. Data gathered during NCS, however, should be available which reflect the actual numbers (latency, amplitude, etc.), preferably in a tabular (not narrative) format. The reason for referral and a clear diagnostic impression are required for each study. In cases where a review becomes necessary, a hard copy of waveforms and/or a complete written report with an interpretation of the test, sufficient to evidence the necessity, must be submitted upon request.
Normal findings and abnormalities uncovered during the study should be documented with the muscles tested, the presence and type of spontaneous activity, as well as the characteristics of the voluntary unit potentials and interpretation.
The HCPCS/CPT code(s) may be subject to Correct Coding Initiative (CCI) edits in addition to guidance in this LCD. Please refer to the CCI for correct coding guidelines and specific applicable code combinations prior to billing. Whichever guidance is more restrictive should be adhered to.
When the documentation does not meet the criteria for the service rendered or the documentation does not establish the medical necessity for the services, such services will be denied as not reasonable and necessary under Section 1862(a)(1) of the Social Security Act.
When requesting an individual consideration through the written redetermination (formerly appeal) process, providers must include all relevant medical records and literature that supports the request. At a minimum two (2) Phase II studies (human feasibility studies suggesting efficacy, pilots) or one (1) Phase III study (primary evidence of safety and efficacy, pivotal) must be submitted for the Medical Director's review.
Utilization Guidelines
It is expected that these services would be performed as indicated by current medical literature and/or standards of practice. When services are performed in excess of established parameters, they may be subject to review for medical necessity.
Each descriptor (code) from codes 95907, 95908, 59509, 95910, 95911, 95912, and 95913 can be reimbursed only once per nerve, or named branch of a nerve, regardless of the number of sites tested or the number of methods used on that nerve. For instance, testing the ulnar nerve at wrist, forearm, below elbow, above elbow, axilla and supraclavicular regions will all be considered as a single
